Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: Angiographic and histologic characterization

Investigative Ophthalmology and Visual Science

Volumn 43, Issue 7, 2002, Pages 2384-2391

  Zacks, David N ^a   Ezra, Eric ^a   Terada, Yoshiko ^a   Michaud, Norman ^a   Connolly, Edward ^a   Gragoudas, Evangelos S ^a   Miller, Joan W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADJUVANT THERAPY; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; ELECTRON MICROSCOPY; HISTOLOGY; MICROSCOPY; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; SUBRETINAL NEOVASCULARIZATION;

ANIMALS; CHOROID; CHOROIDAL NEOVASCULARIZATION; FLUORESCEIN ANGIOGRAPHY; LASER SURGERY; MODELS, ANIMAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RATS; RATS, INBRED BN; RETINA;

EID: 0036293749     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2
2. Verteporfin in Photodynamic Therapy Study Group Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-Year results of a randomized clinical trial - VIP report no. 1
3. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin
4. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes
5. Photodynamic therapy
6. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy: Selective treatment of choroidal neovascularization in monkeys
7. Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey
8. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment
9. VEGF is a major stimulator in model of choroidal neovascularization
10. Vascular endothelial growth factor and ocular neovascularization
11. Changing therapeutic paradigms for exudative age-related macular degeneration: Antiangiogenic agents and photodynamic therapy
12. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate
13. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment
14. Photodynamic therapy using Lu-Tex induces apoptosis in vitro, and its effect is potentiated by angiostatin in retinal capillary endothelial cells
15. A new model of experimental choroidal neovascularization in the rat
16. Calculation of a new Meeh constant and experimental determination of bum size
17. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzophorphyrin
18. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of a single treatment in a phase 1 and 2 study
19. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of retreatment in a phase 1 and 2 study